Home/Pipeline/Vast Therapeutics Programs

Vast Therapeutics Programs

Resistant Bacterial Infections & Severe Respiratory Diseases

Development Stage (Pre-clinical)Active

Key Facts

Indication
Resistant Bacterial Infections & Severe Respiratory Diseases
Phase
Development Stage (Pre-clinical)
Status
Active
Company

About KNOW Bio

KNOW Bio is a privately held life science incubator founded in 2015, built upon two core technology platforms: nitric oxide delivery and precision light therapy. The company creates and funds subsidiary ventures (e.g., EmitBio, Vast Therapeutics, Revian) to develop products for diverse indications, from infectious diseases to dermatology and diabetes care. Its strategy involves advancing subsidiaries to proof-of-concept before seeking exits via sale, IPO, or financing to fund the broader portfolio and generate investor returns.

View full company profile